The New York Times, August 27, 2010

More than two years after the Food and Drug Administration began receiving complaints about the failure of a hip replacement implant made by the DePuy Orthopaedics unit of Johnson & Johnson,  the company said Thursday that it was recalling two kinds of hip implants. DePuy said that it had made the decision to withdraw the products because many patients required a second hip replacement after the company’s implants had failed. The news compounded problems for Johnson & Johnson, which has recalled a succession of some of its best-selling and best-known products, including liquid children’s Tylenol in the United States and, just this week, Acuvue contact lenses in Japan and other countries in Asia and Europe. The Tylenol recall led to the temporary closing of a plant owned by the McNeil Consumer Health Care unit, which is the subject of a federal inquiry over its handling of recent recalls of over-the-counter products.



Facebook icon
LinkedIn icon
Twitter icon